These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 4979932)

  • 41. Ethambutol in unresponsive childhood tuberculosis.
    Mankodi NA; Amdekar YK; Desai AG; Patel BD; Raichur GS
    Indian Pediatr; 1970 Apr; 7(4):202-11. PubMed ID: 5311828
    [No Abstract]   [Full Text] [Related]  

  • 42. [Controlled triple therapy of tuberculosis. Preliminary report].
    Morbach SG; Farnesi A; Corrêa B; Haddad R; Barbosa ZL
    Hospital (Rio J); 1970 Jan; 77(1):317-28. PubMed ID: 4192347
    [No Abstract]   [Full Text] [Related]  

  • 43. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1976 Nov; 2(7995):1102-4. PubMed ID: 62946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
    Virsik K; Kruty R; Matula F; Badalik L
    Probl Tuberk; 1978 Oct; (10):28-30. PubMed ID: 714902
    [No Abstract]   [Full Text] [Related]  

  • 46. [A study on the intensive chemotherapy for previously untreated pulmonary tuberculosis--comparison of two regimens, SM-INH-RFP and SM-INH-EB (author's transl)].
    Maekawa N; Kuze F; Inaba N; Ohi Y; Yamada E; Yasubuchi Y
    Kekkaku; 1977 Jun; 52(6):299-306. PubMed ID: 904139
    [No Abstract]   [Full Text] [Related]  

  • 47. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 48. Rifampin in initial treatment of advanced pulmonary tuberculosis.
    Corpe RF; Sanchez ES
    Chest; 1972 Jun; 61(6):564-73. PubMed ID: 5032152
    [No Abstract]   [Full Text] [Related]  

  • 49. [Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. 2. Comparison of SM, EB and INH regimen with that of SM, PAS and INH for experimental tuberculosis of mice].
    Makiyama H
    Kekkaku; 1971 Aug; 46(8):303-8. PubMed ID: 5570128
    [No Abstract]   [Full Text] [Related]  

  • 50. Ethambutol/INH. in the initial treatment of pulmonary tuberculosis.
    Ng KC
    Singapore Med J; 1971 Jun; 12(3):161-5. PubMed ID: 5094425
    [No Abstract]   [Full Text] [Related]  

  • 51. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
    Suzuyama Y; Shigeno Y; Shigeno H; Nakazato H; Nagasawa M; Koga H; Tomita H; Tomonaga A; Yamaguchi K; Izumikawa K
    Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapeutic results of freshly diagnosed pulmonary tuberculosis EMB in association with SM and INH administered both continuously and intermittently].
    Zierski M
    Gruzlica; 1970; 38(7):723-4. PubMed ID: 5453682
    [No Abstract]   [Full Text] [Related]  

  • 53. [Short course chemotherapy for pulmonary tuberculosis with duration for 6 months after sputum negative conversion. (Report 1)--Report of the 19--20th A series of controlled trial of chemotherapy--(author's transl)].
    Kekkaku; 1979 Jan; 54(1):51-61. PubMed ID: 107362
    [No Abstract]   [Full Text] [Related]  

  • 54. A study of 200 cases of active, recent pulmonary tuberculosis treated with rifampin-isoniazid. A follow-up history of one and one-half to three years.
    Constans P; Baron A; Parrot R; Coury C
    Chest; 1972 Jun; 61(6):539-49. PubMed ID: 4624276
    [No Abstract]   [Full Text] [Related]  

  • 55. A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex.
    Ahn CH; Ahn SS; Anderson RA; Murphy DT; Mammo A
    Am Rev Respir Dis; 1986 Sep; 134(3):438-41. PubMed ID: 3530069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.
    Jindani A; Doré CJ; Mitchison DA
    Am J Respir Crit Care Med; 2003 May; 167(10):1348-54. PubMed ID: 12519740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Follow-up studies up to 2 years of pulmonary tuberculosis patients submitted to the primary chemotherapy for 1 year with multiple drugs including ethambutol].
    Kekkaku; 1973 Apr; 48(4):135-41. PubMed ID: 4721805
    [No Abstract]   [Full Text] [Related]  

  • 59. Ethambutol compared to streptomycin in original treatment of advanced pulmonary tuberculosis.
    Bobrowitz ID
    Chest; 1971 Jul; 60(1):14-21. PubMed ID: 4255171
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.